Table 2.
Cohort | Platelet Doubling | Overall Response | Univariable Model | Multivariable Modela | ||||
---|---|---|---|---|---|---|---|---|
Yes (N) | No (N) | OR (95% CI) | P value (Wald) | N | OR (95% CI) | P value (Wald) | ||
Overall | No | 46 (46%) | 53 (54%) | 0.30 (0.12, 0.78) | 0.01 | 105 | 0.35 (0.11, 1.14) | 0.08 |
Yes | 20 (74%) | 7 (26%) | ||||||
MDS/oligoblastic AML | No | 38 (48%) | 41 (52%) | 0.26 (0.09, 0.77) | 0.02 | 87 | 0.29 (0.08, 1.03) | 0.056 |
Yes | 18 (78%) | 5 (22%) |
MDS: Myelodysplastic syndromes, AML Acute myeloid leukemia.
Adjusted by cytogenetics risk group and presence of peripheral blood blasts.